Keyphrases
Genetic Variants
100%
Statins
100%
Mendelian Randomization
100%
UK Biobank
100%
Cancer Risk
100%
Confidence Interval
33%
Low-density Lipoprotein Cholesterol (LDL-C)
33%
Odds Ratio
33%
Statin Therapy
33%
Lipid-lowering Treatment
33%
Gene-rich Regions
33%
Non-associated
16%
Independent Pathway
16%
Low-density Lipoprotein Receptor
16%
Using Evidence
16%
Lipids
16%
Cholesterol
16%
Targeted Treatment
16%
Oncogenic Role
16%
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9)
16%
Site-specific Cancer
16%
Lipid Effects
16%
APOC3
16%
Alternative Lipids
16%
Human Genetics
16%
HMGCR Gene
16%
Anticarcinogenic Effects
16%
Niemann-Pick C1-like 1 (NPC1L1)
16%
Medicine and Dentistry
Statin
100%
Mendelian Randomization Analysis
100%
Cancer Risk
100%
UK Biobank
100%
Low Density Lipoprotein Cholesterol
33%
Odds Ratio
33%
Malignant Neoplasm
16%
Carcinogenesis
16%
Cancer
16%
Human Genetics
16%
Pharmacology, Toxicology and Pharmaceutical Science
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Statin (Protein)
50%
Low Density Lipoprotein Cholesterol
50%
Malignant Neoplasm
25%
Carcinogenesis
25%
NPC1L1
25%